AstraZeneca’s Tagrisso Recommended for Approval in EU for Unresectable EGFR-Mutated NSCLC

Foundation Medicine Receives FDA Approval for FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® in NSCLC

Exact Sciences Partners with Carlos Ponce to Boost Colorectal Cancer Awareness in the Hispanic Community

Merck Receives Positive CHMP Opinion for KEYTRUDA® in Combination Therapy for First-Line Treatment of Non-Epithelioid Mesothelioma

Australia Launches Genomics Australia to Lead Advances in Genomic Medicine

Sidra Medicine Unveils Masterclasses Ahead of PMFG 2024 Summit

FDA Approves Revuforj® as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation

CHMP Recommends Approval of Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

ADDF Invests $1.18M to Standardize p-tau217 Blood Tests for Alzheimer’s Diagnosis

GSK Reports Positive Interim Results for DREAMM-7 Trial of Blenrep in Multiple Myeloma

Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Home
/
insight
/
details

Machine learning and missense mutation

NextEdge Admin

03 Sep 2023

4 min 43 sec

Machine learning techniques are increasingly being used in the field of genetics and genomics, including the analysis of missense mutations. Missense mutations are a type of genetic mutation in which a single nucleotide change in the DNA sequence leads to the substitution of one amino acid in a protein with another. These mutations can have significant implications for the structure and function of the protein, potentially leading to various diseases. Here’s how machine learning is applied to the analysis of missense mutations:

Variant Classification: Machine learning algorithms can be trained to classify missense mutations into different categories based on their predicted impact on protein function. Common categories include “benign,” “likely benign,” “pathogenic,” and “likely pathogenic.” These algorithms use various features, such as sequence conservation, structural information, and functional annotations, to make predictions.
Pathogenicity Prediction: Machine learning models can be trained to predict the pathogenicity of missense mutations, which means determining whether a specific mutation is likely to cause disease. These models consider a wide range of features, including sequence information, conservation scores, and known disease associations.
Functional Impact Assessment: Machine learning can help assess the functional impact of missense mutations on proteins. By analyzing features like protein structure, solvent accessibility, and interaction interfaces, these models can predict whether a mutation is likely to disrupt the protein’s function or stability.
Cancer Genomics: In cancer genomics, machine learning is used to analyze missense mutations in tumor samples. These analyses can identify driver mutations that are responsible for the growth and progression of cancer. Machine learning models can prioritize mutations that are more likely to be therapeutically actionable.
Drug Discovery: Machine learning can aid in drug discovery by predicting the potential of targeting specific missense mutations with precision medicine approaches. These models can identify mutations that are more likely to respond to targeted therapies or predict how a mutation might affect drug binding sites.

Clinical Decision Support: Machine learning algorithms can assist clinicians in making informed decisions about patient care. By analyzing a patient’s genetic data, including missense mutations, these algorithms can help determine the most appropriate treatment options or predict
disease risks.
Genomic Medicine: Machine learning is an integral part of the emerging field of genomic medicine. It allows for the integration of large-scale genomic data, including missense mutations, with clinical
data to provide personalized treatment and prevention strategies.

It’s important to note that the accuracy of machine learning models in missense mutation analysis depends on the quality and quantity of data used for training and validation. Additionally, these models are continuously evolving as more data becomes available and our understanding of genetics and genomics deepens. Machine learning is a valuable tool for handling the complexity of missense mutation analysis and is helping advance our knowledge of how genetic variations contribute to human health and disease.

Related Tags

Machine learning

missense mutation

What is CAR-T cell therapy?

Top Reviews

No reviews yet